Murphy Oil Corporation (MUR)
NYSE: MUR · Real-Time Price · USD
23.63
-0.22 (-0.92%)
At close: Aug 6, 2025, 4:00 PM
23.63
0.00 (0.00%)
After-hours: Aug 6, 2025, 7:00 PM EDT
Verve Therapeutics Stock Forecast
Stock Price Forecast
The 13 analysts that cover Verve Therapeutics stock have a consensus rating of "Hold" and an average price target of $28.62, which forecasts a 21.12% increase in the stock price over the next year. The lowest target is $23 and the highest is $40.
Price Target: $28.62 (+21.12%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Verve Therapeutics stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 3 | 2 | 1 | 1 | 1 | 1 |
| Hold | 9 | 9 | 12 | 12 | 12 | 12 |
| Sell | 1 | 2 | 2 | 2 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 15 | 15 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Hold Maintains $24 → $26 | Hold | Maintains | $24 → $26 | +10.03% | Jul 22, 2025 |
| Scotiabank | Scotiabank | Hold Maintains $22 → $26 | Hold | Maintains | $22 → $26 | +10.03% | Jul 11, 2025 |
| Barclays | Barclays | Sell Maintains $22 → $23 | Sell | Maintains | $22 → $23 | -2.67% | Jul 7, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $26 → $24 | Hold | Maintains | $26 → $24 | +1.57% | Jun 26, 2025 |
| Morgan Stanley | Morgan Stanley | Sell Maintains $27 → $26 | Sell | Maintains | $27 → $26 | +10.03% | May 23, 2025 |
Financial Forecast
Revenue This Year
2.71B
from 3.02B
Decreased by -10.09%
Revenue Next Year
2.86B
from 2.71B
Increased by 5.42%
EPS This Year
1.57
from 2.70
Decreased by -41.77%
EPS Next Year
2.51
from 1.57
Increased by 59.54%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 3.0B | 3.3B | 3.4B |
| Avg | 2.7B | 2.9B | 3.0B |
| Low | 2.4B | 2.6B | 2.7B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.1% | 20.8% | 18.1% |
| Avg | -10.1% | 5.4% | 6.6% |
| Low | -19.2% | -5.8% | -5.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.52 | 3.79 | 5.04 | ||
| Avg | 1.57 | 2.51 | 3.37 | ||
| Low | 0.53 | 1.17 | 1.81 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -6.7% | 141.0% | 100.8% | ||
| Avg | -41.8% | 59.5% | 34.3% | ||
| Low | -80.4% | -25.9% | -27.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.